Works by Marquez, Loreta

Results: 3
    1

    Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00629-1
    By:
    • Cohen, Adam D.;
    • Parekh, Samir;
    • Santomasso, Bianca D.;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W. C. J.;
    • Arnulf, Bertrand;
    • Mateos, Maria-Victoria;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • De Braganca, Kevin C.;
    • Schecter, Jordan M.;
    • Marquez, Loreta;
    • Lee, Erin;
    • Cornax, Ingrid;
    • Zudaire, Enrique;
    • Li, Claire;
    • Olyslager, Yunsi;
    • Madduri, Deepu;
    • Varsos, Helen;
    • Pacaud, Lida
    Publication type:
    Article
    2
    3

    A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 4, p. 547, doi. 10.1111/bjh.14708
    By:
    • Laubach, Jacob P.;
    • Moslehi, Javid J.;
    • Francis, Sanjeev A.;
    • San Miguel, Jesús F.;
    • Sonneveld, Pieter;
    • Orlowski, Robert Z.;
    • Moreau, Philippe;
    • Rosiñol, Laura;
    • Faber, Edward A.;
    • Voorhees, Peter;
    • Mateos, Maria ‐ Victoria;
    • Marquez, Loreta;
    • Feng, Huaibao;
    • Desai, Avinash;
    • Velde, Helgi;
    • Elliott, Jennifer;
    • Shi, Hongliang;
    • Dow, Edward;
    • Jobanputra, Nishith;
    • Esseltine, Dixie ‐ Lee
    Publication type:
    Article